Program Leader, Next Wave

Position Responsibilities:

• Strategic Program Leadership
• Serve as the Program Leader (PL) for assigned pipeline assets, holding accountability for the development and execution of the Integrated Development Plan (IDP), consisting of overall project timeline to regulatory approval
• Drive assets through major inflection points (e.g., advancing program to development, IND enablement, Clinical Phase 1 to 2 transitions).
• Lead the cross-functional Program Team (PT), facilitating high-quality decision-making and ensuring alignment across cross-functional partners and integrating across Research & Development
• Lead the definition and maintenance of the Target Product Profile (TPP), in collaboration with cross-functional partners
• End-to-End Process & Risk Management
• Apply a strong understanding of end-to-end drug development, process management, and organizational interdependencies to anticipate challenges before they become critical path blockers and partner with the team to develop mitigation strategies
• Proactively identify, articulate, escalate, and manage program risks; collaborate with key stakeholders to recommend constructive solutions rather than just reporting on status.
• Communication & Enterprise Leadership
• Act as the central communication hub, ensuring effective and timely communication to team members and senior leadership regarding program status, key milestones, and strategic pivots.
• Foster a culture of collaboration and accountability, resolving conflicts within the team and ensuring all functions are moving in lockstep.

Candidate Requirements:

• Advanced degree preferred (e.g., PhD, PharmD, or MBA); real-world experience in life sciences is required
• The ideal candidate will have prior experience working on pre-clinical or clinical stage programs in either neurology or neuromuscular diseases.
• The ideal candidate will have direct, hands-on experience on drug development in a clinical stage program across either clinical research, biostatistics, or regulatory affairs
• Proven track record of moving a clinical-stage molecule through a major inflection point or interface (e.g., Research to Development, Clinical Phase 1 to 2, or Clinical to Commercial)

Skills & Capabilities:

• Utility Player: Demonstrated ability to flex between high-level strategy and hands-on execution with an entrepreneurial spirit.
• End-to-End Fluency: Strong understanding of the drug development lifecycle, from discovery target validation through to commercial launch.
• Leadership: Exceptional communication and interpersonal skills with the ability to lead without authority and influence stakeholders across the organization.
• Operational Excellence: Extremely well-organized with the ability to manage multiple programs and drive clarity in complex, ambiguous situations